Type II diabetes mellitus and impaired glucose regulation in Caucasian children and adolescents with obesity living in Germany

International Journal of Obesity

Volumn 28, Issue 2, 2004, Pages 307-313

  Wabitsch, M ^a   Hauner, H ^b   Hertrampf, M ^a   Muche, R ^a   Hay, B ^a   Mayer, H ^c   Kratzer, W ^a   Debatin, K M ^a   Heinze, E ^a  

^a UNIVERSITY OF ULM   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c Children's Hospital Hochried   (Germany)

Author keywords

Impaired glucose regulation; Obesity in children and adolescents; Type II diabetes

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN; LIPID;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CAPILLARY BLOOD; CAUCASIAN; CHILD; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETIC OBESITY; DIET RESTRICTION; FAMILY HISTORY; FEMALE; GERMANY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEMOSTASIS; HOSPITAL ADMISSION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; PRIORITY JOURNAL; SCREENING; VENOUS BLOOD; WEIGHT REDUCTION;

EID: 1242284365     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0802555     Document Type: Article

References (33)

1. Rocchini AP. Childhood obesity and a diabetes epidemic. N Engl J Med 2002; 346: 802-810.
2. WHO. Obesity. Preventing and managing the global epidemic. Report of a WHO consultation on obesity, WHO technical report Series 894, 2000.
3. Rosenbloom AL, Joe JR, Young RS, Winter NE. Emerging epidemic of type 2 diabetes in youth. Diabetes Care 1999; 22: 345-354.
4. Fagot-Campagna A, Pettitt DJ, Engelgau MM, Burrows NR, Geiss LS, Valdez R, Beckles GL, Saadine J, Gregg EW, Williamson DF, Narayan KM. Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J Pediatr 2000; 136: 644-672.
5. American Diabetes Association. Type 2 diabetes in children and adolescents. Diabetes Care 2000; 23: 381-389.
6. Dabelea D, Hanson RL, Bennett PH, Roumain J, Knowler WC, Pettitt DJ. Increasing prevalence of type II diabetes in American Indian children. Diabetologia 1998; 41: 904-910.
7. Dabelea D, Pettitt DJ, Jones KL, Arslanian SA. Type 2 diabetes mellitus in minority children and adolescents. An emerging problem. Endocrinol Metab Clin N Am 1999; 28: 709-729.
8. Glaser NS, Jones KL. Non-insulin dependent diabetes mellitus in Mexican-American children. W J Med 1998; 168: 11-16.
9. Harris SB, Gittelson J, Hanley A, Barnie A, Wolever T, Gao J. The prevalence of NIDDM in native Canadians. Diabetes Care 1997; 20: 185-187.
10. Fagot-Campagna A, Saaddine JB, Flegal KM, Beckles GLA. Diabetes, impaired fasting glucose, and elevated HbA1c in US adolescents: the third National Health and Nutrition Examination Survey. Diabetes Care 2001; 24: 834-837.
11. Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, Savoye M, Rieger V, Taksali S, Barbetta G, Sherwin RS, Caprio S. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002; 346: 802-810.
12. Livingstone B. Epidemiology of childhood obesity in Europe. Eur J Pediatr 2001; 159 (Suppl 1): S14-S34.
13. Kromeyer-Hauschild K, Zellner K, Jaeger U, Hoyer H. Prevalence of overweight and obesity among school children in Jena (Germany). Int J Obes Relat Metab Disord 1999; 23: 1143-1150.
14. Drake AJ, Smith A, Betts PR, Crowne EC, Shield JP. Type 2 diabetes in obese white children. Arch Dis Child 2002; 86: 207-208.
15. The DECODE Study Group. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 1999; 354: 617-621.
16. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hamalainen H, Hanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M, Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-1350.
17. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
18. Kromeyer-Hauschild K, Wabitsch M, Kunze D, Geller F, Ziegler A, Geiß HC, Hesse V, Hippel V, Jäger U, Johnsen D, Kiess W, Korte W, Menner K, Müller M, Niemann-Pilatus A, Remer T, Schäfer F, Wittchen HU, Zabransky S, Zellenr K, Hebebrand J. Perzentile für den Body-mass-Index für das Kindes-und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatsschr Kinderheilkd 2001; 149: 807-818.
19. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969; 44: 291.
20. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in boys. Arch Dis Child 1970; 45: 13.
21. Alberti K. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Diabetes Med 1999; 15: S39-S53.
22. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2002; 25 (Suppl 1): S5-S20.
23. Cole TJ. The LMS method for constructing normalized growth standards. Eur J Clin Nutr 1990; 44: 45-60.
24. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
25. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G, Alberiche M, Bonadonna RC, Muggeo M. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 1998; 47: 1643-1649.
26. Velho G, Froguel P. Genetic metabolic and clinical characteristics of maturity onset diabetes of the young. Eur J Endocrinol 1998; 138: 233-239.
27. Stride A, Vaxillaire M, Tuomi T, Barbetti F, Niolstad PR, Hansen T, Costa A, Conget I, Pedersen O, Sovik O, Lorini R, Groop L, Froguel P, Hattersley AT. The genetic abnormality in the beta cell determines the response to an oral glucose load. Diabteologia 2002; 45: 427-435.
28. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994; 17: 961-969.
29. Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995; 22: 481-486.
30. Edelstein SL, Knowler WC, Bain RP, Anders R, Barrett-Connor EL, Dowse GK, Haffner SM, Pettitt DJ, Sorkin JD, Muller DC, Collins VR, Hamman RF. Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes 1997; 46: 701-710.
31. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed prediabetic individuals: does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 1990; 263: 2893-2899.
32. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmever HM, Byrd-Holt DD. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 1998; 21: 518-524.
33. Lim S, Tai E, Tan B, Chew S, Tan C. Cardiovascular risk profile in individuals with borderline glycaemia: the effect of the 1997 American Diabetes Association diagnostic criteria and the 1998 World Health Organization Provisional Report. Diabetes Care 2000; 23: 278-282.